Vaccines, Sage advice and hot Scott

This week on Energy Voice Out Loud, in association with the EIC, podders Allister, Ed and Mark weighed up the prospects of oil and gas offshore workers getting their hands on the vaccine any time soon, imbued with the wisdom of a top microbiologist. 

Meanwhile, an activist investor told ExxonMobil bosses to start chasing money, not demand. Sage advice, but not always heeded by sector chiefs. 

And lastly, what’s hot in the North Sea? Scott’s hot! CNOOC wants help tying the Ravel well back to its Scott platform without breaking the bank. That’s the same platform that Parkmead wants to use to develop its Greater Perth Area, while Hunting trialled its organic oil recovery technology there. What does that say about reports that CNOOC is trying to sell the platform? 

Energy Voice helps organisations understand the geopolitical, economic and financial factors that underpin market events, and give you a view on what’s coming over the horizon. As a listener to this podcast, you can get a free trial of energyvoice.com, giving you two weeks of unrestricted access to the latest crucial news and insight. The trial is entirely without obligation – we don’t want your credit card, and there’s no auto-enrolment at the end. 

📧 Email trials@energyvoice.com to get the best market analysis in the world, free. 

🗣 To find out how to speak to over one million qualified users in global energy, through our peerless digital news and insight platform, visit https://www.energyvoice.com/content-services 

Bookmark and subscribe to energyvoice.com, sign up to our newsletter, and follow us on LinkedIn and Twitter. 

Ⓛ https://www.linkedin.com/showcase/energy-voice 

ⓣ https://twitter.com/EnergyVoiceNews 

• To accept the trial offer, email trials@energyvoice.com providing your name. 
• One of our sales team will set up as a user of the Energy Voice website, apply your trial allowance and email you to provide access instructions. 
• You will have two weeks of unlimited access from the point at which the trial allowance is instigated. At the end of the trial period you will retain your user account but will only be able to view a restricted number of articles as a free registered user (currently four per month). 
• You will not be automatically enrolled on a paid subscription at the end of the trial period. A member of the sales team will contact you to find out if you are interested in subscribing, provide options for subscription and payment if so, and process the transaction with your authorisation. Alternatively you can purchase a subscription directly from the website. 
• We retain the right to terminate trials and free registered user accounts without notice or explanation.